ArticleCellular and molecular bioengineering2019

Dual Inhibitors-Loaded Nanotherapeutics that Target Kinase Signaling Pathways Synergize with Immune Checkpoint Inhibitor.

Anujan Ramesh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.